Given that patients with type 2 diabetes are a high-risk population for cardiovascular events [3], beneficial vascular effects of the metabolite GLP-1(9-36) on the cardiovascular system are therefore of potential clinical interest. This evidence concerns the gene GCG and type 2 diabetes mellitus.